Skip to main navigation Skip to search Skip to main content

Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206

  • Kristie A. Blum
  • , Jeffrey L. Johnson
  • , Donna Niedzwiecki
  • , George P. Canellos
  • , Bruce D. Cheson
  • , Nancy L. Bartlett

Research output: Contribution to journal › Article › peer-review

57   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Single agent bortezomib in the treatment of relapsed and refractory Hodgkin lymphoma: Cancer and leukemia Group B protocol 50206'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science